Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Zollinger-Ellison Syndrome × Pantoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Zollinger-Ellison Syndrome 1 Vomiting 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Neoplasms 1 Ototoxicity 1 Osteosarcoma 1 Neoplasm Metastasis 1 Gastrinoma 1 Duodenal Neoplasms 1 Breast Neoplasms 1

Interventions

pazopanib 1 YF 476 1 Temozolomide 1 Streptozocin 1 Pantoprazole 1 Omeprazole 1 Interferons 1 Fluorouracil 1 Doxorubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00001191 2017-07-02

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Zollinger-Ellison Syndrome, Gastrinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡